Tracked deals
9
9 tracked deals across 2019-2026.
Paris, France
Independent French private equity specialist with ~€3.7B capital under management, investing via multiple strategies (Private Equity including Tilt, Entrepreneurs, Territoires, Midcap, ETI; Venture Capital via XAnge; and Private Debt), with offices across France and an international footprint (e.g., Milan, Berlin, Brussels) and partnerships in Africa and North America.
Tracked deals
9
9 tracked deals across 2019-2026.
Recent pace
2
2 tracked deals announced in the last 12 months.
Deal mix
Buyout
5 buyout · 2 addon · 2 growth capital
Last 6 years
Supporting Data
Siparex Midcap 4, together with co-investor Insec Equity Partners, acquired a majority stake in Corali Group in an ownership-transition deal. The Corali family (including CEO Graziella Corali) retains a minority stake to support management and strategic continuity, with plans to accelerate international expansion (notably North America) and execute an active build-up strategy.
Siparex ETI has signed an agreement to acquire a majority stake in ATK Sports, a global leader in ski mountaineering bindings, from Progressio SGR. The deal also includes the Indulti family and other financial investors, with plans to accelerate international expansion and expand ATK’s “hybrid” bindings and new outdoor product lines.
TiLT Capital Partners has acquired a 38% stake in Spain-based Negratín Global Services, with SWEN Capital Partners also participating in the minority investment. The growth-capital investment will support Negratín's expansion into larger-scale EPC projects, accelerate the roll-out of its own photovoltaic plants as an IPP, and strengthen international expansion while the founders remain majority shareholders.
ARCHIMED, together with partners CAPZA Flex Equity Mid‑Market and Siparex, funded three concurrent add-on acquisitions by CARSO: Italian Arace Laboratori, French food‑safety specialist AQCF, and a grouping of three asbestos testing laboratories carved out from AC Environnement. The deals, financed by equity from shareholders and a debt facility arranged by Tikehau Capital, strengthen CARSO's position as France's market leader in health‑at‑work and purity testing and accelerate its European consolidation strategy.
TiLT Capital Partners (Siparex Group) led a €10 million minority financing round in Deltalys, with participation from SWEN Capital Partners and existing shareholders. The investment will fund expansion of Deltalys's production capacity, geographic roll-out in France, Europe and North America, and strengthening of R&D to broaden applications of its ECOLYS biogas filtration solution.
Mérieux Equity Partners' MP4 fund has signed a definitive agreement to acquire a controlling majority stake in Piercan, with Groupe Siparex and regional investor Normandie Participations investing alongside. The deal is a primary LBO that will support Piercan — a Normandy-based, global manufacturer of isolator and dry-box gloves for the pharmaceutical and nuclear industries — to improve industrial capabilities, pursue international expansion and diversify into new market segments; the founding Lucas family and other historical shareholders reinvest part of their proceeds.
French lab testing leader CARSO Group has acquired Agro.Biolab Laboratory, a Bari-based Italian food-safety testing company. The add-on was financed by CARSO's majority owner ARCHIMED with partners CAPZA Flex Equity Mid-Market and Siparex; the Agro.Biolab founder's family will roll over a significant portion of proceeds into a minority stake in CARSO.
Transatlantic healthcare private equity firm ARCHIMED, via its MED Platform I fund and in partnership with CAPZA Expansion and Siparex, has acquired a majority stake in Lyon-based CARSO, a leader in purity and analytical testing for pharma, healthcare, environmental and food sectors. The deal (debt provided by Tikehau Capital and several banks) will support CARSO's internationalization and service-range expansion as the group aims to more than double current annual revenues (above €200 million).
Siparex ETI, with co-investors Carvest, BNP Paribas Développement, AfricInvest and Desjardins Capital, signed an agreement to acquire a majority stake in Sintex NP, the European arm of India's Sintex Group. Sintex NP is a leading European processor of polymers, composites and precision metal engineering with ~2,800 employees and €275m in sales (2018); the investment will support accelerated growth via acquisitions and international expansion, particularly into North America.
Turn tracked acquisition activity into an outreach-ready buyer list.